Comparing two fertility drugs in Japanese women with hormone deficiency
Treatments studied
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study tests if a combination of two hormone drugs (follitropin alfa/lutropin alfa) works as well as another drug (hMG) for Japanese women with low LH and FSH levels who are doing in vitro fertilization (IVF). The goal is to help them produce eggs for pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a premenopausal woman who wants to get pregnant
- You have been diagnosed with low levels of LH and FSH (hormones needed for egg growth)
- You have had at most one previous IVF attempt without becoming pregnant
- You are of Japanese ethnicity
- An ultrasound shows your ovaries are normal with at least 5 tiny egg-containing follicles on each side
- Your male partner has had a semen analysis showing the sperm is suitable for IVF
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a one-time injection medicine (corifollitropin alfa) to help older women produce eggs for IVF. It aims to see if this medicine is safe and works well for women aged 36 to 40 with normal ovarian function.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
This study tests whether adding a hormone called r-hLH to standard IVF treatment helps women aged 35 to 40 produce better eggs and improve their chances of pregnancy. It is for women who are on their first or second cycle of assisted reproduction.
This trial is studying whether a specific fertility medication (hMG) helps improve embryo quality during IVF when you are also doing genetic testing of embryos. It may help you have better embryos for transfer.
This study looks at how follitropin delta is used in real clinics to help women stimulate eggs for IVF or ICSI. It may help doctors fine-tune dosing by comparing outcomes in everyday practice.
This trial compares two different ways of stimulating the ovaries in women who have a poor response to fertility treatment. It aims to see which method gives a higher chance of having a live baby.
Hear when a new Infertility trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.